Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > 2005

Publikationen 2005

Adam D, Thon L.
Mouse fibrosarcoma cells transfected with GFP plasmid.
IBA, BioTAGnology Newsletter, 4, 2005

Adam-Klages S, Adam D, Janssen O, Kabelitz D.
Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.
Immunol Res 33: 149-166, 2005

Baum W, Kirkin V, Mateus Fernández S B, Pick R, Lettau M, Janssen O, Zörnig M.
Binding in the intracellular Fas Ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.
J Biol Chem 280: 40012-40024, 2005

Budagian V, Bulanova E, Orinska Z, Thon L, Mamat U, Bellosta P, Basilico C, Adam D, Paus R, Bulfone-Paus S.
A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.
EMBO J 24: 4260-4270, 2005

Bulanova E, Budagian V, Orinska Z, Hein M, Petersen F, Thon L, Adam D, Bulfone-Paus S.
Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells.
J Immunol 74: 3880-3890, 2005

Csehi SB, Mathieu,S, Seifert U, Lange A, Zweyer A, Wernig A, Adam D.
Tumor necrosis factor (TNF) interferes with insulin signalling through the p55 TNF receptor death domain.
Biochem Bioph Res Co 329: 397-405, 2005

Falk M, Paulsen M, Adam-Klages S.
Caspases and proliferation.
Signal Transduction 6: 350-355,2005

Hilpert F, Heiser A, Kabelitz D, Pfisterer J, Jonat W.
Immuntherapie gynäkologischer Malignome.
Onkologe 11: 530-535, 2005

Hilpert F, Heiser A, Wieckhorst W, Arnold N, Kabelitz D, Jonat W, Pfisterer J.
The impact of electrical charge on the viability and physiology of dendritic cells.
Scand J Immunol 62: 399-406, 2005

Holtmeier W, Kabelitz D.
gamma/delta-T cells link innate and adaptive immune responses.
Chem Immunol Allergy 86:151-83, 2005

Janssen O, Hass R.
Editorial: Apoptosis - live and let die.
Signal Transduction 5: 293-296, 2005

Jensen JM, Förl M, Winoto-Morbach S, Seite S, Schunck M, Proksch E, Schütze S.
Acid and neutral spingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging.
Exp Dermatol 14: 609-618, 2005

Kabelitz D.
Immunologie - Gefahren-Management im Körper (Immunology - How to control danger).
Dtsch Med Wochenschr 130: 1563-1565, 2005

Kabelitz D, Marischen L, Oberg H-H, Holtmeier W, Wesch D.
Epithelial defence by gamma/delta T cells.
Int Arch Allergy Immunol 173: 73-81, 2005

Kling C, Steinmann, J, Magez J, Westphal E, Kabelitz D.
Akute Nebenwirkung der allogenen Lymphozyten-Immunisierung.
Geburtsh Frauenheilk 65: 404-413, 2005

Lange A, Thon L, Mathieu S, Adam D.
Apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor.
Biochem Bioph Res Comm 335: 575-583, 2005

Linkermann A, Qian, J, Lettau M, Kabelitz D, Janssen O.
Considering Fas ligand as a target for therapy.
Exp Opin Ther Targets 9: 119-134, 2005

Lüschen S, Falk M, Scherer G, Ussat S, Paulsen M, Adam-Klages S.
The Fas-aassociated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK.
Exp Cell Res 310: 33-42, 2005

Marget M, Bohlsen D, Davarnia P, Yoo-Ott K, Kabelitz D, Skerra A, Steinmann J.
A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
Mol Immunol 42: 643-649, 2005

Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S, Weichenthal M, Abecasis GR, Qin ZS, Christophers E, Lim HW, Voorhees JJ, Elder JT.
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association.
J Invest Dermatol 125 : 395-396, 2005

Pan J, Heiser A, Marget M, Steinmann J, Kabelitz D.
Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Gene Ther 12: 742-750, 2005

Quian J, Lettau M, Podda G, Janssen O.
FasL associated factors and their potential role in the regulation of FasL expression.
Signal Transduction 4: 195-2001, 2005

Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T.
Activation of Vgamma9/Vdelta2 T cells by NKG2D.
J Immunol 175: 2144-2151, 2005

Scheruebl C, Schneider-Brachert W, Schütze S, Helgans T, Männel D.
Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type II.
J Inflamm 2: 7, 2005

Senkpiehl I, Marget M, Wedler M, Jenisch S, Georgi J, Kabelitz D, Steinmann J.
HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
Int Arch Allergy Immunol 137: 315-318, 2005

Thon L, Möhlig H, Mathieu S, Lange A, Bulanova E, Winoto-Morbach S, Schütze S, Bulfone-Paus S, Adam D.
Ceramide mediates caspase-independent programmed cell death.
FASEB Journal, 19: 1945-1956, 2005

Weise J, Maune S, Kabelitz D, Heiser A.
Bedeutung dendritischer Zellen für die Immuntherapie von Tumorerkrankungen.
HNO 53:117-20, 2005

Wesch D, Marischen L, Kabelitz D.
Regulation of cytokine production by gamma/delta-T cells.
Curr Med Chem 4: 153-160, 2005

Wessing, J, Brecht S, Claussen M, Roemer L, Goetz M, Bigini P, Schütze S, Herdegen T.
Tumor necrosis factor-alpha receptor I (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons.
Eur J Neurosci 22: 267-272, 2005